

AMCP eModel is the ultimate tool for communication of health economic models and value evidence. Find out more about this tech partnership and this health economic modeling platform to support the exchange of clinical and economic information between manufacturers and payers.

AMCP partners with FormularyDecisions to enhance information sharing and formulary decision-making by creating a platform for current, credible, and compliant information exchange between life science companies and active, qualified healthcare decision-makers.
Featured






-
Health Information Technology Resources
-
Digital Therapeutics Resources
-
Health Disparities Resources
-
Value-Based Contracts Resources
Meetings Proceedings & Findings
View More


Latest News & Resources

View our Market Insights webinar that features an enlightening exploration of the intersection between mental health and rare diseases.

Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.

Read the Journal of Managed Care + Specialty Pharmacy (JMCP) February 2025 Issue

The AMCP Poster Abstract Program provides a forum for authors to share their research with the managed care pharmacy community.

People with rare diseases often have mental health challenges related to their health care. These vary by disease, but there are common issues that make it difficult for individuals and their families, including delays in getting diagnosed, not knowing what will happen in the future, having limited treatments, and facing financial difficulties.

View our Market Insights webinar that features a candid conversation with panelists from AMCP's Market Insights Roundtable on Optimizing the Management of Inherited Blood Disorders, Part 2 - a follow-up program to the 2022 Roundtable.

Panel of experts discussing targeted therapies to deliver improved patient outcomes in oncology.

Exploring opportunities to improve the quality of life for those with Amyotrophic Lateral Sclerosis (ALS)

The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide feedback on the “Medicare $2 Drug List Model” issued by CMS.

View our Market Insights webinar to explore the latest practice recommendations in the management and treatment of food allergies.

In a world where innovative therapies are entering the market at an unprecedented pace, stakeholders need quick access to reliable information to help ensure the health care system is working as it should. They need fresh perspectives and data to keep up with how tools and techniques are working to help maintain balance in the managed care ecosystem. Enter AMCP’s recently released 2024 Access, Affordability, and Outcomes (AAO) report, which serves as a useful guide on how managed care pharmacy tools drive impact for patients.

Welcome to the latest update from Professional Affairs! This fall has been packed with major developments—from the release of Maximum Fair Prices for Medicare drugs to continued government focus of pharmacy benefit managers and much more.